LEADER 04071nam 2200709Ia 450 001 9910456407003321 005 20210618221018.0 010 $a1-282-35824-3 010 $a9786612358241 010 $a0-520-93928-X 010 $a1-59734-450-8 024 7 $a10.1525/9780520939288 035 $a(CKB)111090529079620 035 $a(EBL)224570 035 $a(OCoLC)808037855 035 $a(SSID)ssj0000092615 035 $a(PQKBManifestationID)11114332 035 $a(PQKBTitleCode)TC0000092615 035 $a(PQKBWorkID)10023398 035 $a(PQKB)10348720 035 $a(MiAaPQ)EBC224570 035 $a(DE-B1597)518878 035 $a(OCoLC)55538532 035 $a(DE-B1597)9780520939288 035 $a(Au-PeEL)EBL224570 035 $a(CaPaEBR)ebr10057097 035 $a(CaONFJC)MIL235824 035 $a(EXLCZ)99111090529079620 100 $a20031010d2004 uy 0 101 0 $aeng 135 $aurnn#---|u||u 181 $ctxt 182 $cc 183 $acr 200 15$aThe $800 million pill$b[electronic resource] $ethe truth behind the cost of new drugs /$fMerrill Goozner 210 $aBerkeley $cUniversity of California Press$d2004 215 $a1 online resource (304 p.) 300 $aDescription based upon print version of record. 311 0 $a0-520-24670-5 311 0 $a0-520-23945-8 320 $aIncludes bibliographical references and index. 327 $tFront matter --$tContents --$tIntroduction --$tPART ONE. BIOHYPE --$tPART TWO. DIRECTED RESEARCH --$tPART THREE. BIG PHARMA --$tNotes --$tBibliography --$tAcknowledgments --$tIndex 330 $aWhy do life-saving prescription drugs cost so much? Drug companies insist that prices reflect the millions they invest in research and development. In this gripping exposé, Merrill Goozner contends that American taxpayers are in fact footing the bill twice: once by supporting government-funded research and again by paying astronomically high prices for prescription drugs. Goozner demonstrates that almost all the important new drugs of the past quarter-century actually originated from research at taxpayer-funded universities and at the National Institutes of Health. He reports that once the innovative work is over, the pharmaceutical industry often steps in to reap the profit. Goozner shows how drug innovation is driven by dedicated scientists intent on finding cures for diseases, not by pharmaceutical firms whose bottom line often takes precedence over the advance of medicine. A university biochemist who spent twenty years searching for a single blood protein that later became the best-selling biotech drug in the world, a government employee who discovered the causes for dozens of crippling genetic disorders, and the Department of Energy-funded research that made the Human Genome Project possible--these engrossing accounts illustrate how medical breakthroughs actually take place. The$800 Million Pill suggests ways that the government's role in testing new medicines could be expanded to eliminate the private sector waste driving up the cost of existing drugs. Pharmaceutical firms should be compelled to refocus their human and financial resources on true medical innovation, Goozner insists. This book is essential reading for everyone concerned about the politically charged topics of drug pricing, Medicare coverage, national health care, and the role of pharmaceutical companies in developing countries. 517 3 $aEight hundred million dollar pill 606 $aPrescription pricing 606 $aDrugs$xPrices 606 $aPharmaceutical industry 606 $aConsumer education 608 $aElectronic books. 615 0$aPrescription pricing. 615 0$aDrugs$xPrices. 615 0$aPharmaceutical industry. 615 0$aConsumer education. 676 $a338.4/3/61510973 700 $aGoozner$b Merrill$f1950-$01044163 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910456407003321 996 $aThe$92469630 997 $aUNINA